Lisdexamfetamine Dimesylate
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Mylan Pharmaceuticals Inc. | generic | 7 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 7 | SUPPLYING |
| AvKARE | relabeler | 6 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Mylan Pharmaceuticals Inc., a Viatris Company. Therapeutic category: Psychiatry.
Lisdexamfetamine Dimesylate Capsule — reported in shortage by Amneal Pharmaceuticals. Therapeutic category: Psychiatry.
